Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.77 [1.25-2.52],0.00136025681066795,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL18A1,Collagen alpha-1(XVIII) chain,Wald ratio,1,0.58 [0.4-0.83],0.00306472396952407,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Wald ratio,1,1.54 [1.11-2.16],0.0107723376618511,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.63 [0.43-0.93],0.0189192248633024,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CKB,Creatine kinase B-type,Wald ratio,1,0.64 [0.44-0.94],0.0220249401980067,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA1,Ephrin-A1,Wald ratio,1,0.66 [0.45-0.95],0.0257056139224491,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Wald ratio,1,0.68 [0.48-0.96],0.0274137345444882,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN2,Nectin-2,Wald ratio,1,0.66 [0.45-0.96],0.0283745761507377,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.46 [1.03-2.08],0.0324851478813248,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Wald ratio,1,0.67 [0.46-0.98],0.0372047510695302,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MSR1,Macrophage scavenger receptor types I and II,Wald ratio,1,1.44 [1.02-2.02],0.0374463986049051,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD59,CD59 glycoprotein,Wald ratio,1,1.47 [1.02-2.12],0.0387469916441095,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPP1,Osteopontin,Wald ratio,1,0.68 [0.48-0.99],0.0416458280268204,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIP2,Cysteine-rich protein 2,Wald ratio,1,1.45 [1.01-2.09],0.0438662950946334,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCS1,Neuronal calcium sensor 1,Wald ratio,1,1.41 [1-2],0.0523855644615691,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGA11,Integrin alpha-11,Wald ratio,1,1.44 [0.99-2.09],0.0545593211332562,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACE2,Angiotensin-converting enzyme 2,Wald ratio,1,1.4 [0.99-1.99],0.0561517066181298,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Wald ratio,1,1.42 [0.99-2.03],0.0561941298419851,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGAV,Integrin alpha-V,Wald ratio,1,1.42 [0.99-2.04],0.0582036114868214,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.43 [0.98-2.09],0.0629368274831056,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD46,Membrane cofactor protein,Wald ratio,1,0.7 [0.47-1.02],0.0661768505500064,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Wald ratio,1,1.39 [0.97-2],0.0722188955014455,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD14,Monocyte differentiation antigen CD14,Wald ratio,1,0.71 [0.48-1.03],0.0725322886351362,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DLL1,Delta-like protein 1,Wald ratio,1,0.72 [0.5-1.04],0.0819917188599028,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ICAM1,Intercellular adhesion molecule 1,Wald ratio,1,0.73 [0.51-1.04],0.083499741319847,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GPR37,Prosaposin receptor GPR37,Wald ratio,1,0.75 [0.54-1.04],0.0845486427854707,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC1A,C-type lectin domain family 1 member A,Wald ratio,1,0.73 [0.51-1.05],0.089611704959576,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.72 [0.5-1.06],0.0931128572211114,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE6,Ribonuclease K6,Wald ratio,1,1.35 [0.95-1.92],0.0945937823122665,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PSAP,Prosaposin,Wald ratio,1,0.73 [0.5-1.06],0.0960456262094567,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GAST,Gastrin,Wald ratio,1,1.37 [0.94-1.99],0.0967268704273524,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VWC2,Brorin,Wald ratio,1,0.75 [0.53-1.05],0.0984856721758305,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TIMP1,Metalloproteinase inhibitor 1,Wald ratio,1,0.73 [0.49-1.07],0.102177928086229,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.74 [0.52-1.06],0.103853015337865,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LMNB2,Lamin-B2,Wald ratio,1,0.74 [0.51-1.07],0.108835088301397,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Wald ratio,1,0.74 [0.51-1.08],0.116432836206868,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DCN,Decorin,Wald ratio,1,1.34 [0.93-1.93],0.120794343708912,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.75 [0.52-1.1],0.138666392215161,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL3,C-C motif chemokine 3,Wald ratio,1,0.76 [0.52-1.1],0.145983188742441,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC5A,C-type lectin domain family 5 member A,Wald ratio,1,0.77 [0.53-1.1],0.15065167908551,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD274,Programmed cell death 1 ligand 1,Wald ratio,1,0.77 [0.53-1.1],0.151222075821955,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP7,Matrilysin,Wald ratio,1,0.76 [0.53-1.1],0.151816231235498,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TPP1,Tripeptidyl-peptidase 1,Wald ratio,1,0.76 [0.52-1.11],0.154296455899742,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Wald ratio,1,0.77 [0.53-1.11],0.158280521573074,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EDN1,Endothelin-1,Wald ratio,1,1.31 [0.9-1.91],0.164607537656169,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC3B,Tetranectin,Wald ratio,1,1.31 [0.9-1.91],0.164693525759759,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LIFR,Leukemia inhibitory factor receptor,Wald ratio,1,1.3 [0.9-1.89],0.167099684782539,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Wald ratio,1,1.23 [0.92-1.64],0.167911903641319,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Wald ratio,1,0.77 [0.53-1.12],0.169468041015795,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS9,Galectin-9,Wald ratio,1,0.78 [0.54-1.12],0.177409380280235,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINT1,Kunitz-type protease inhibitor 1,Wald ratio,1,1.29 [0.89-1.89],0.177711396522679,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS1,Galectin-1,Wald ratio,1,0.78 [0.54-1.13],0.183267746326486,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.25 [0.89-1.75],0.19047354759612,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CKAP4,Cytoskeleton-associated protein 4,Wald ratio,1,0.79 [0.54-1.14],0.205858567922017,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.25 [0.88-1.76],0.209382332297555,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Wald ratio,1,1.21 [0.89-1.64],0.229820720213374,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Wald ratio,1,1.23 [0.87-1.74],0.237700567620126,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RBFOX3,RNA binding protein fox-1 homolog 3,Wald ratio,1,1.24 [0.87-1.77],0.23854749559198,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CA12,Carbonic anhydrase 12,Wald ratio,1,1.25 [0.86-1.83],0.240989464412898,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EGFR,Epidermal growth factor receptor,Wald ratio,1,1.24 [0.86-1.79],0.241130895985531,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,0.82 [0.59-1.15],0.2443644002164,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MERTK,Tyrosine-protein kinase Mer,Wald ratio,1,1.24 [0.86-1.78],0.245077548041242,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.8 [0.54-1.17],0.250055218935685,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN3,CCN family member 3,Wald ratio,1,1.22 [0.87-1.73],0.253087235181673,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK4,Kallikrein-4,Wald ratio,1,0.84 [0.62-1.14],0.259361737830866,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON2,Spondin-2,Wald ratio,1,0.81 [0.56-1.17],0.259657336157659,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Wald ratio,1,1.22 [0.86-1.71],0.261040980170115,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Wald ratio,1,0.81 [0.56-1.18],0.274563106153683,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,1.23 [0.84-1.79],0.280312916446567,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSL,Cathepsin L1,Wald ratio,1,1.22 [0.85-1.77],0.280858212771302,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Wald ratio,1,0.83 [0.6-1.16],0.28112736938458,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF2,Trefoil factor 2,Wald ratio,1,1.21 [0.84-1.75],0.301242534569769,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Wald ratio,1,0.82 [0.57-1.19],0.303821792772292,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.18 [0.86-1.6],0.305507724225099,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC7A,C-type lectin domain family 7 member A,Wald ratio,1,0.86 [0.64-1.15],0.307987413313856,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GM2A,Ganglioside GM2 activator,Wald ratio,1,0.84 [0.6-1.18],0.316294001020411,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CST3,Cystatin-C,Wald ratio,1,0.84 [0.59-1.19],0.318013864911664,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGL1,Fibrinogen-like protein 1,Wald ratio,1,0.86 [0.64-1.16],0.320770624106994,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS4,Galectin-4,Wald ratio,1,1.19 [0.84-1.68],0.323837496008354,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD302,CD302 antigen,Wald ratio,1,1.2 [0.83-1.73],0.325995229931331,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1R1,Interleukin-1 receptor type 1,Wald ratio,1,1.2 [0.83-1.73],0.332819601176873,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL10RB,Interleukin-10 receptor subunit beta,Wald ratio,1,0.84 [0.6-1.19],0.333448203957845,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Wald ratio,1,0.84 [0.58-1.2],0.336418262124855,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.19 [0.84-1.69],0.337324046444386,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NEFL,Neurofilament light polypeptide,Wald ratio,1,0.85 [0.61-1.19],0.33866271681101,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSF1,Macrophage colony-stimulating factor 1,Wald ratio,1,0.83 [0.57-1.21],0.340014925674557,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WNT9A,Protein Wnt-9a,Wald ratio,1,0.84 [0.59-1.2],0.348125377017674,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL7,C-C motif chemokine 7,Wald ratio,1,0.84 [0.58-1.21],0.349460966326604,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL15,C-C motif chemokine 15,Wald ratio,1,1.19 [0.82-1.73],0.350218145451202,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF1,Trefoil factor 1,Wald ratio,1,1.19 [0.83-1.7],0.352890093753123,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL14,C-C motif chemokine 14,Wald ratio,1,0.83 [0.57-1.23],0.357975713706902,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Wald ratio,1,0.86 [0.61-1.19],0.359424403814009,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP1,"Fatty acid-binding protein, liver",Wald ratio,1,1.19 [0.82-1.72],0.365082738121945,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ULBP2,UL16-binding protein 2,Wald ratio,1,0.85 [0.6-1.2],0.365545274452858,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.84 [0.57-1.24],0.369529086411586,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Wald ratio,1,1.18 [0.82-1.69],0.375317769804789,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Wald ratio,1,0.85 [0.58-1.24],0.396108353121392,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR2,Folate receptor beta,Wald ratio,1,1.17 [0.81-1.68],0.401127362780653,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PALM2,Paralemmin-2,Wald ratio,1,1.16 [0.81-1.68],0.416258542146969,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL21,C-C motif chemokine 21,Wald ratio,1,0.86 [0.59-1.25],0.418724421829165,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ELN,Elastin,Wald ratio,1,1.12 [0.84-1.5],0.434778777453353,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCDC80,Coiled-coil domain-containing protein 80,Wald ratio,1,1.15 [0.81-1.62],0.4357225185927,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,0.87 [0.6-1.25],0.441793681079976,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPPB,Natriuretic peptides B,Wald ratio,1,0.86 [0.59-1.26],0.441992429566286,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Wald ratio,1,0.88 [0.63-1.23],0.446823297257548,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VEGFA,Vascular endothelial growth factor A,Wald ratio,1,0.88 [0.63-1.22],0.449813170653869,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REN,Renin,Wald ratio,1,1.15 [0.8-1.65],0.457665672009468,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Wald ratio,1,0.86 [0.59-1.27],0.458656167447417,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Wald ratio,1,0.88 [0.62-1.24],0.459906160730111,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,UMOD,Uromodulin,Wald ratio,1,1.12 [0.83-1.5],0.468186241953423,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Wald ratio,1,0.87 [0.6-1.27],0.468627603501171,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Wald ratio,1,0.87 [0.6-1.27],0.472529573991403,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGF23,Fibroblast growth factor 23,Wald ratio,1,0.87 [0.6-1.27],0.474270033386357,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPC2,NPC intracellular cholesterol transporter 2,Wald ratio,1,0.87 [0.6-1.27],0.475952421063691,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD160,CD160 antigen,Wald ratio,1,0.87 [0.6-1.27],0.476510164053002,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300E,CMRF35-like molecule 2,Wald ratio,1,0.87 [0.6-1.27],0.476843452493278,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHA2,Ephrin type-A receptor 2,Wald ratio,1,1.15 [0.79-1.67],0.479310530173221,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SHISA5,Protein shisa-5,Wald ratio,1,1.14 [0.79-1.64],0.480630887165304,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AREG,Amphiregulin,Wald ratio,1,1.15 [0.78-1.68],0.486344827553482,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Wald ratio,1,1.12 [0.81-1.54],0.487416163351954,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFA,Protransforming growth factor alpha,Wald ratio,1,0.87 [0.6-1.28],0.488388427113649,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON1,Spondin-1,Wald ratio,1,0.88 [0.62-1.25],0.48910652440656,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,JAM2,Junctional adhesion molecule B,Wald ratio,1,0.88 [0.61-1.27],0.491776553195091,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NRP1,Neuropilin-1,Wald ratio,1,1.14 [0.79-1.64],0.492371620123374,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADGRG2,Adhesion G-protein coupled receptor G2,Wald ratio,1,1.13 [0.8-1.6],0.497294930193945,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GFRA1,GDNF family receptor alpha-1,Wald ratio,1,0.88 [0.62-1.27],0.499021762426561,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL6A3,Collagen alpha-3(VI) chain,Wald ratio,1,1.14 [0.78-1.64],0.500419206706925,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15,Interleukin-15,Wald ratio,1,0.88 [0.6-1.29],0.504825652695414,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL4A1,Collagen alpha-1(IV) chain,Wald ratio,1,0.88 [0.61-1.28],0.505865278642732,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PTGDS,Prostaglandin-H2 D-isomerase,Wald ratio,1,0.88 [0.61-1.28],0.508655988999431,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,INHBB,Inhibin beta B chain,Wald ratio,1,0.89 [0.62-1.27],0.513678418783153,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Wald ratio,1,0.9 [0.64-1.25],0.524894550783605,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Wald ratio,1,0.89 [0.62-1.28],0.527267632637104,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Wald ratio,1,1.12 [0.79-1.58],0.532870059248831,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Wald ratio,1,1.11 [0.8-1.55],0.533504584367045,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Wald ratio,1,1.11 [0.79-1.57],0.534318293091503,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.13 [0.77-1.64],0.534876924238378,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Wald ratio,1,0.91 [0.66-1.24],0.536567077388788,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HPGDS,Hematopoietic prostaglandin D synthase,Wald ratio,1,1.12 [0.78-1.6],0.538096525361598,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARF2,Scavenger receptor class F member 2,Wald ratio,1,1.1 [0.8-1.53],0.548272329485208,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADM,Pro-adrenomedullin,Wald ratio,1,0.9 [0.63-1.28],0.554832793315556,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AMBP,Protein AMBP,Wald ratio,1,1.11 [0.78-1.6],0.558987787810535,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA4,Ephrin-A4,Wald ratio,1,1.12 [0.77-1.63],0.562265096387728,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.9 [0.62-1.3],0.565329950506636,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RL1,Interleukin-1 receptor-like 1,Wald ratio,1,1.09 [0.82-1.45],0.56793757986001,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Wald ratio,1,0.9 [0.63-1.29],0.572988738834379,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Wald ratio,1,0.91 [0.66-1.26],0.574156621843728,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Wald ratio,1,1.1 [0.78-1.55],0.578931231857624,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Wald ratio,1,0.9 [0.63-1.29],0.58008822516876,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXADR,Coxsackievirus and adenovirus receptor,Wald ratio,1,1.11 [0.76-1.62],0.583047374081127,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD48,CD48 antigen,Wald ratio,1,1.1 [0.78-1.54],0.584824388268123,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Wald ratio,1,1.1 [0.77-1.57],0.590181784428648,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR1,Folate receptor alpha,Wald ratio,1,1.1 [0.77-1.59],0.590636963087073,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRSS8,Prostasin,Wald ratio,1,1.1 [0.77-1.59],0.59087754774329,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSZ,Cathepsin Z,Wald ratio,1,1.1 [0.77-1.59],0.599222776284249,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLXNB2,Plexin-B2,Wald ratio,1,1.09 [0.79-1.49],0.600602984972759,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN4,Nectin-4,Wald ratio,1,1.1 [0.76-1.6],0.600798886913953,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Wald ratio,1,1.09 [0.78-1.54],0.606700498662716,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PDCD1,Programmed cell death protein 1,Wald ratio,1,0.91 [0.63-1.32],0.614536097104927,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.91 [0.63-1.32],0.617453467988385,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Wald ratio,1,1.09 [0.77-1.53],0.633440576688288,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAYN,Layilin,Wald ratio,1,1.09 [0.77-1.54],0.640191384041861,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RSPO3,R-spondin-3,Wald ratio,1,0.92 [0.64-1.31],0.640571810246149,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARB2,Lysosome membrane protein 2,Wald ratio,1,1.09 [0.76-1.54],0.643467740031427,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Wald ratio,1,0.92 [0.63-1.33],0.647267645833639,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHRDL1,Chordin-like protein 1,Wald ratio,1,0.92 [0.66-1.3],0.649837310426873,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRAP1,Proline-rich acidic protein 1,Wald ratio,1,1.09 [0.76-1.55],0.649959686084282,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BSG,Basigin,Wald ratio,1,0.92 [0.63-1.33],0.65129446185668,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD80,T-lymphocyte activation antigen CD80,Wald ratio,1,0.92 [0.64-1.32],0.654637898780777,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RBP2,Retinol-binding protein 2,Wald ratio,1,1.09 [0.74-1.6],0.674597905272033,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFBR2,TGF-beta receptor type-2,Wald ratio,1,0.93 [0.64-1.33],0.676619890064572,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.93 [0.64-1.33],0.680193170438514,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE1,Ribonuclease pancreatic,Wald ratio,1,1.08 [0.75-1.55],0.685070605634455,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BAMBI,BMP and activin membrane-bound inhibitor homolog,Wald ratio,1,0.92 [0.63-1.36],0.687360849267574,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Wald ratio,1,0.94 [0.66-1.33],0.708501829782945,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL18BP,Interleukin-18-binding protein,Wald ratio,1,0.93 [0.64-1.35],0.712584600002778,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF3,Trefoil factor 3,Wald ratio,1,1.07 [0.74-1.54],0.715839063041245,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Wald ratio,1,1.07 [0.75-1.53],0.717112024196801,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN4,CCN family member 4,Wald ratio,1,0.94 [0.67-1.32],0.717308915399271,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADA2,Adenosine deaminase 2,Wald ratio,1,1.07 [0.74-1.55],0.724201046796747,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD4,T-cell surface glycoprotein CD4,Wald ratio,1,1.07 [0.74-1.55],0.724308143058037,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASET2,Ribonuclease T2,Wald ratio,1,0.94 [0.66-1.34],0.736957096294664,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLAUR,Urokinase plasminogen activator surface receptor,Wald ratio,1,0.94 [0.65-1.36],0.739574337319216,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIGLEC1,Sialoadhesin,Wald ratio,1,1.06 [0.74-1.51],0.743327574384022,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL2RA,Interleukin-2 receptor subunit alpha,Wald ratio,1,0.95 [0.67-1.33],0.749906755348992,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Wald ratio,1,0.94 [0.65-1.38],0.758446101105005,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FAM3C,Protein FAM3C,Wald ratio,1,0.94 [0.65-1.36],0.758474732372613,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL1,Follistatin-related protein 1,Wald ratio,1,1.06 [0.72-1.57],0.759215473374563,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BST2,Bone marrow stromal antigen 2,Wald ratio,1,0.94 [0.65-1.37],0.759936222008835,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.94 [0.64-1.38],0.760232935616711,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Wald ratio,1,0.94 [0.65-1.38],0.76214513226415,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Wald ratio,1,1.05 [0.75-1.49],0.764271420817131,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Wald ratio,1,0.95 [0.66-1.36],0.772744569127232,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG4,Regenerating islet-derived protein 4,Wald ratio,1,0.95 [0.66-1.37],0.772881082393822,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD83,CD83 antigen,Wald ratio,1,0.95 [0.65-1.38],0.779268347209417,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.95 [0.66-1.37],0.784171638851262,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Wald ratio,1,0.95 [0.66-1.38],0.792424934348212,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGFR2,Fibroblast growth factor receptor 2,Wald ratio,1,1.05 [0.73-1.5],0.793409227996017,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GUCA2A,Guanylin,Wald ratio,1,0.95 [0.66-1.38],0.798156991356542,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300C,CMRF35-like molecule 6,Wald ratio,1,0.95 [0.66-1.38],0.799505092894981,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG1A,Lithostathine-1-alpha,Wald ratio,1,1.05 [0.72-1.51],0.808182151220768,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OGN,Mimecan,Wald ratio,1,0.96 [0.7-1.32],0.80928451230852,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC6A,C-type lectin domain family 6 member A,Wald ratio,1,0.96 [0.67-1.37],0.810563767883192,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPT2,Angiopoietin-2,Wald ratio,1,1.05 [0.72-1.52],0.811139516998723,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL4R,Interleukin-4 receptor subunit alpha,Wald ratio,1,0.96 [0.66-1.38],0.811314875202421,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DSC2,Desmocollin-2,Wald ratio,1,1.04 [0.72-1.51],0.819479622635847,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTNB,Dystrobrevin beta,Wald ratio,1,1.04 [0.72-1.51],0.823963893582971,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TIMP4,Metalloproteinase inhibitor 4,Wald ratio,1,0.96 [0.68-1.37],0.826422536202649,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD27,CD27 antigen,Wald ratio,1,1.04 [0.72-1.51],0.830126321922127,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIRPB1,Signal-regulatory protein beta-1,Wald ratio,1,0.97 [0.71-1.31],0.831855802838733,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Wald ratio,1,0.96 [0.68-1.37],0.834118687726151,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHI3L1,Chitinase-3-like protein 1,Wald ratio,1,0.96 [0.68-1.36],0.835114433863942,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Wald ratio,1,0.96 [0.67-1.39],0.837682163563532,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SEPTIN8,Septin-8,Wald ratio,1,0.96 [0.67-1.39],0.844085265449605,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SLAMF8,SLAM family member 8,Wald ratio,1,0.96 [0.67-1.38],0.844636256443591,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGRN,Agrin,Wald ratio,1,0.97 [0.67-1.39],0.851724968145721,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSO,Cathepsin O,Wald ratio,1,0.97 [0.66-1.4],0.854046424407497,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VCAM1,Vascular cell adhesion protein 1,Wald ratio,1,0.97 [0.66-1.41],0.857433178523642,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PI3,Elafin,Wald ratio,1,0.97 [0.67-1.39],0.86487263852379,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EDA2R,Tumor necrosis factor receptor superfamily member 27,Wald ratio,1,1.03 [0.76-1.39],0.871436289759581,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Wald ratio,1,0.97 [0.68-1.38],0.874376363883328,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Wald ratio,1,0.97 [0.68-1.39],0.874889900552709,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Wald ratio,1,1.03 [0.72-1.47],0.876431268741177,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK11,Kallikrein-11,Wald ratio,1,0.97 [0.67-1.41],0.878328005256111,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TAFA5,Chemokine-like protein TAFA-5,Wald ratio,1,1.03 [0.7-1.51],0.879749315319474,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP12,Macrophage metalloelastase,Wald ratio,1,1.02 [0.74-1.43],0.88421635936504,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ASGR1,Asialoglycoprotein receptor 1,Wald ratio,1,1.03 [0.7-1.5],0.890977878491774,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIGR,Polymeric immunoglobulin receptor,Wald ratio,1,0.97 [0.66-1.43],0.892704462957242,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPDC1,Neural proliferation differentiation and control protein 1,Wald ratio,1,0.98 [0.68-1.41],0.894755476763696,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Wald ratio,1,1.02 [0.73-1.43],0.896973048446247,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL3,Follistatin-related protein 3,Wald ratio,1,0.98 [0.68-1.41],0.899656269264566,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN5,CCN family member 5,Wald ratio,1,0.98 [0.7-1.38],0.901679241343316,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP3,"Fatty acid-binding protein, heart",Wald ratio,1,1.02 [0.72-1.46],0.905149018024333,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RETN,Resistin,Wald ratio,1,1.02 [0.7-1.48],0.906797072343852,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHGA,Chromogranin-A,Wald ratio,1,1.02 [0.7-1.49],0.907218687539672,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD276,CD276 antigen,Wald ratio,1,1.02 [0.75-1.39],0.907786874021137,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,B2M,Beta-2-microglobulin,Wald ratio,1,1.02 [0.71-1.47],0.90796300409695,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS3,Galectin-3,Wald ratio,1,1.02 [0.74-1.41],0.908598427739294,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PGF,Placenta growth factor,Wald ratio,1,1.02 [0.72-1.44],0.911603940429575,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Wald ratio,1,0.98 [0.67-1.42],0.917270158798133,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RN,Interleukin-1 receptor antagonist protein,Wald ratio,1,1.02 [0.7-1.49],0.919397795331307,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSTB,Cystatin-B,Wald ratio,1,1.02 [0.73-1.41],0.92003299514604,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG3A,Regenerating islet-derived protein 3-alpha,Wald ratio,1,1.02 [0.71-1.46],0.924016350207055,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LY6D,Lymphocyte antigen 6D,Wald ratio,1,1.02 [0.71-1.46],0.92763385820713,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Wald ratio,1,0.98 [0.68-1.42],0.927750917218539,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Wald ratio,1,1.02 [0.7-1.48],0.928139468113364,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OCLN,Occludin,Wald ratio,1,1.02 [0.7-1.48],0.932991369976313,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Wald ratio,1,0.99 [0.69-1.4],0.935907902936379,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXCL9,C-X-C motif chemokine 9,Wald ratio,1,0.99 [0.69-1.4],0.944961050101406,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL19,Interleukin-19,Wald ratio,1,0.99 [0.69-1.41],0.948902353246509,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COLEC12,Collectin-12,Wald ratio,1,0.99 [0.7-1.4],0.952024015302628,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.01 [0.71-1.45],0.955725777976416,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DPT,Dermatopontin,Wald ratio,1,1.01 [0.72-1.41],0.957680624801789,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BCAN,Brevican core protein,Wald ratio,1,1.01 [0.7-1.46],0.959460898224146,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Wald ratio,1,0.99 [0.68-1.43],0.960587902708385,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CDCP1,CUB domain-containing protein 1,Wald ratio,1,1.01 [0.73-1.4],0.962038576676769,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MDK,Midkine,Wald ratio,1,1.01 [0.69-1.47],0.965253933353471,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Wald ratio,1,1.01 [0.7-1.44],0.965332273743088,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TCN2,Transcobalamin-2,Wald ratio,1,0.99 [0.73-1.35],0.965739689465365,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Wald ratio,1,0.99 [0.72-1.38],0.967001716959235,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.99 [0.69-1.43],0.972277916210879,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLA2G15,Phospholipase A2 group XV,Wald ratio,1,0.99 [0.69-1.44],0.975454963830533,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SDC1,Syndecan-1,Wald ratio,1,0.99 [0.69-1.44],0.978613850181559,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CNTN5,Contactin-5,Wald ratio,1,1 [0.73-1.36],0.98362576774233,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLMP,CXADR-like membrane protein,Wald ratio,1,1 [0.71-1.42],0.98381161609075,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NELL1,Protein kinase C-binding protein NELL1,Wald ratio,1,1 [0.7-1.44],0.986337713409064,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,C7,Complement component C7,Wald ratio,1,1 [0.71-1.4],0.990637223577624,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1 [0.69-1.46],0.99340344406832,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Wald ratio,1,1 [0.7-1.43],0.998500419235515,trans
